We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.125 | -2.67% | 4.55 | 4.11 | 4.99 | 4.41 | 4.35 | 4.39 | 482,311 | 16:35:06 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.41M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 09/11/2020 12:43 | Buy at 50-60p for tomorrows DCB. | jibba jabber | |
| 09/11/2020 12:40 | From the BBC: ‘The data presented is not the final analysis. It is based on the first 94 volunteers to test positive for Covid - the precise effectiveness of the vaccine may change when the full results are analysed. The companies say they will have enough safety data by the third week of November to take their vaccine to regulators. Until then it is not possible for countries to begin their vaccination campaigns.’ | wetdream | |
| 09/11/2020 12:36 | Under 100p now... this was the obvious elephant in the room tbf... did say they are now fully funded for COPD trials... wonder if they will continue with the COVID? | g2theary |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
